Skip to Main Content

Author Details

Sung Tae Kim
Busan Paik Hospital, Inje University
1996
764
66
PMIDPaper TitleJournal TitlePublished Year
37814113Mortality rate and causes of death in papillary thyroid microcarcinoma.Endocrine2024
37814113Mortality rate and causes of death in papillary thyroid microcarcinoma.Endocrine2024
37789514Microsurgical treatment of distal middle cerebral artery aneurysm: A single-center review.J Cerebrovasc Endovasc Neurosurg2024
37789514Microsurgical treatment of distal middle cerebral artery aneurysm: A single-center review.J Cerebrovasc Endovasc Neurosurg2024
34913378Usefulness of Pointwise Encoding Time Reduction with Radial Acquisition-Magnetic Resonance Angiography after Endovascular Treatment for Intracranial Aneurysms.Interv Neuroradiol2023
35681110A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.Cancer Res Treat2023
37948420Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.PLoS One2023
37751561Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.J Clin Oncol2023
37840606Acute Onset of Syndrome of the Trephined After Lumboperitoneal Shunt Placement: A Case Report.Korean J Neurotrauma2023
37744267Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.Oncol Res2023
37654198Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.Cancer Med2023
38002099The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy.Biomedicines2023
38000030Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.Sci Adv2023
37730953Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.Sci Rep2023
37648323Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study.Anticancer Res2023
37800766Increasing discrepancy of MR imaging and CSF study in patients with leptomeningeal seeding from lung adenocarcinoma after targeted therapy using a tyrosine kinase inhibitor.Medicine (Baltimore)2023
37720428Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms.J Gastrointest Oncol2023
37969818Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes.J Gastrointest Oncol2023
37789109Letter to Editor in Response to Article Entitled "Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promotor Mutational Status".Ann Surg Oncol2023
37553133The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric Cancer.J Gastric Cancer2023
36715856ASO Visual Abstract: Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.Ann Surg Oncol2023
37468553Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model.Sci Rep2023
36650632Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers.Cancer Med2023
37395887A Machine Learning Approach Using [<sup>18</sup>F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor.Mol Imaging Biol2023
36637642Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.Ann Surg Oncol2023
37376117Development and Evaluation of Self-Microemulsifying Drug Delivery System for Improving Oral Absorption of Poorly Water-Soluble Olaparib.Pharmaceutics2023
37114287ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.Cancer Res Treat2023
36602760Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea.Thyroid2023
37499191Clinical Implication of <i>HER2</i> Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis.JCO Precis Oncol2023
37163165The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.Therap Adv Gastroenterol2023
34913378Usefulness of Pointwise Encoding Time Reduction with Radial Acquisition-Magnetic Resonance Angiography after Endovascular Treatment for Intracranial Aneurysms.Interv Neuroradiol2023
37720428Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms.J Gastrointest Oncol2023
37800766Increasing discrepancy of MR imaging and CSF study in patients with leptomeningeal seeding from lung adenocarcinoma after targeted therapy using a tyrosine kinase inhibitor.Medicine (Baltimore)2023
37751561Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.J Clin Oncol2023
37553133The Optimal Tumor Mutational Burden Cutoff Value as a Novel Marker for Predicting the Efficacy of Programmed Cell Death-1 Checkpoint Inhibitors in Advanced Gastric Cancer.J Gastric Cancer2023
38002099The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy.Biomedicines2023
38000030Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.Sci Adv2023
37654198Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.Cancer Med2023
37948420Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.PLoS One2023
37789109Letter to Editor in Response to Article Entitled "Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promotor Mutational Status".Ann Surg Oncol2023
37744267Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.Oncol Res2023
37840606Acute Onset of Syndrome of the Trephined After Lumboperitoneal Shunt Placement: A Case Report.Korean J Neurotrauma2023
37648323Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study.Anticancer Res2023
37730953Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.Sci Rep2023
37499191Clinical Implication of <i>HER2</i> Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis.JCO Precis Oncol2023
37969818Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes.J Gastrointest Oncol2023
35681110A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.Cancer Res Treat2023
37114287ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.Cancer Res Treat2023
37468553Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model.Sci Rep2023
37376117Development and Evaluation of Self-Microemulsifying Drug Delivery System for Improving Oral Absorption of Poorly Water-Soluble Olaparib.Pharmaceutics2023
  • 1 - 50 of 1,528

Recommended Authors

Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 1
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Ke Jin
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 1
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 6
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Lin Qi
Xiangya Hospital of Central South University
Career Start Year 2003
Number of shared co-authors 2
Nan Du
Institute for Solid State Physics, Friedrich Schiller University Jena
Career Start Year 2003
Number of shared co-authors 0
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 0
Yen-Lin Chen
34903Fu-Jen Catholic University
Career Start Year 2001
Number of shared co-authors 1
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Shi Yan
Qilu Hospital of Shandong University
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Sung Eun Kim
Haeundae Paik Hospital, Inje University College of Medicine
Career Start Year 1999
Number of shared co-authors 4
Woo Young Kim
Westchester Medical Center
Career Start Year 1998
Number of shared co-authors 3
Sun Young Lee
Chonbuk National University Hospital
Career Start Year 1998
Number of shared co-authors 6
Ji Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1998
Number of shared co-authors 9
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Career Start Year 1998
Number of shared co-authors 35
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Hyo Jin Kim
Department of Food Bioengineering, Jeju National University
Career Start Year 1996
Number of shared co-authors 2
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Career Start Year 1995
Number of shared co-authors 0
Hyun-Soo Kim
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 5
Seung Hoon Lee
Korea University College of Medicine, Korea University Ansan Hospital
Career Start Year 1993
Number of shared co-authors 17
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year 1992
Number of shared co-authors 4
Bing Xia
Xijing Hospital, The Fourth Military Medical University
Career Start Year 1992
Number of shared co-authors 1
Masanori Fukushima
Nagasaki University Graduate School of Biomedical Sciences
Career Start Year 1989
Number of shared co-authors 0
Tian Tian
Beijing Friendship Hospital, Capital Medical University
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 184
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 124
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers 91
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 32
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 29
Min Gew Choi
Research Institute, National Cancer Center
Co-authored papers 28
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 26
Kyung Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 20
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 20
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 18
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 17
Kyunga Kim
Co-authored papers 16
Kyong Soo Park
Co-authored papers 10
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Co-authored papers 10
Michael W Weiner
University of California San Francisco
Co-authored papers 9
Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 9
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Co-authored papers 7
Jusun Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 7
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers 7
Hee-Cheol Kim
Keimyung University School of Medicine
Co-authored papers 7
Taehyang Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Jason K Sa
Korea University, College of Medicine
Co-authored papers 6
Hyunjoo Cha-Molstad
University of Science and Technology
Co-authored papers 6
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Siraj M Ali
Foundation Medicine
Co-authored papers 5
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers 5
Young Min Cho
Co-authored papers 5
In-Hee Lee
Co-authored papers 4
In-Hee Lee
Children's Hospital Boston
Co-authored papers 4
TaeJin Ahn
Co-authored papers 4
Release 1.2